Baseline characteristics
| Characteristic | |
| Age (years) (median (range)) | 60 (29-89) |
| Age <65 years (n (%)) | 79(62.7) |
| Age ≥65 years (n (%)) | 47(37.3) |
| Ethnic origin n(%) | |
| Caucasian | 111(88.1) |
| African | 5(4.0) |
| Asian | 1(0.8) |
| Latin | 9(7.1) |
| Weight (kg) mean (±SD)) | 68.3(±12.4) |
| Body mass index (n (%)) | |
| Normal (<25kg/m2) | 53(42.1) |
| Overweight (25–29.9kg/m2) | 43(34.1) |
| Obesity I–II (30-34.9kg/m2) | 28(22.2) |
| Obesity III–IV(≥≥35 kg/m2) | 2(1.6%) |
| Comorbidity (n(%)) | |
| Hypertension | 42(33.3) |
| Malignancy | 22(17.5) |
| Diabetes | 11(8.7) |
| History of cardiovascular disease | 17(13.5) |
| History of respiratory disease | 7(5.6) |
| Post neoadjuvant treatment | 24(19.0) |
| Disease type (n(%)) | |
| Low–intermediate risk endometrium cancer | 19(15.1) |
| High risk endometrium cancer | 10(7.9) |
| Borderline ovarian tumor | 6(4.8) |
| Early stage ovarian cancer | 3(2.4) |
| Advanced stage ovarian cancer | 5(4.0) |
| Early stage cervical cancer | 3(2.4) |
| Advanced stage cervical cancer | 2(1.6) |
| Breast cancer | 76(60.3) |
| Vulvar cancer | 2(1.6) |
| Age (years) by disease type (median (range)) | |
| Low–intermediate risk endometrium cancer | 60 (29-83) |
| High risk endometrium cancer | 69 (60-89) |
| Borderline ovarian tumor | 52 (40-71) |
| Early stage ovarian cancer | 45 (42-60) |
| Advanced stage ovarian cancer | 63 (43-83) |
| Early stage cervical cancer | 37 (33-62) |
| Advanced stage cervical cancer | 65 (59-71) |
| Breast cancer | 59 (37-81) |
| Vulvar cancer | 73 (60-86) |